Cargando…
Overexpressed integrin alpha 2 inhibits the activation of the transforming growth factor β pathway in pancreatic cancer via the TFCP2-SMAD2 axis
BACKGROUND: Integrin alpha 2 (ITGA2) has been recently reported to be an oncogene and to play crucial roles in tumor cell proliferation, invasion, metastasis, and angiogenesis. Our previous study showed that ITGA2 was overexpressed in pancreatic cancer and promoted its progression. However, the mech...
Autores principales: | Cai, Hongkun, Guo, Feng, Wen, Shuang, Jin, Xin, Wu, Heshui, Ren, Dianyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862343/ https://www.ncbi.nlm.nih.gov/pubmed/35193647 http://dx.doi.org/10.1186/s13046-022-02286-5 |
Ejemplares similares
-
TFCP2 activates beta-catenin/TCF signaling in the progression of pancreatic cancer
por: Yuedi, Dai, et al.
Publicado: (2017) -
TFCP2 Overcomes Senescence by Cooperating With SREBP2 to Activate Cholesterol Synthesis in Pancreatic Cancer
por: Zhang, Dexiang, et al.
Publicado: (2021) -
Neglected Functions of TFCP2/TFCP2L1/UBP1 Transcription Factors May Offer Valuable Insights into Their Mechanisms of Action
por: Taracha, Agnieszka, et al.
Publicado: (2018) -
Transcription factor LSF (TFCP2) inhibits melanoma growth
por: Goto, Yuji, et al.
Publicado: (2015) -
Histone acetyltransferase 1 promotes gemcitabine resistance by regulating the PVT1/EZH2 complex in pancreatic cancer
por: Sun, Yan, et al.
Publicado: (2021)